Literature DB >> 19252440

Feasibility of real-time magnetic resonance-guided angioplasty and stenting of renal arteries in vitro and in Swine, using a new polyetheretherketone-based magnetic resonance-compatible guidewire.

Sebastian Kos1, Rolf Huegli, Eugen Hofmann, Harald H Quick, Hilmar Kuehl, Stephanie Aker, Gernot M Kaiser, Paul J Borm, Augustinus L Jacob, Deniz Bilecen.   

Abstract

OBJECTIVES: Demonstrate the usability of a new polyetheretherketone (PEEK)-based MR-compatible guidewire for renal artery catheterization, angioplasty, and stenting under MR-guidance using MR-visible markers, in vitro and in vivo.
MATERIAL AND METHODS: The new 0.035'' guidewire with fiber-reinforced PEEK core, a soft tip, and a hydrophilic coating was used. Paramagnetic markings were coated on the wire and nonbraided catheters for passive visualization. Bending stiffness of the guidewire was compared with available hydrophilic guidewires (Terumo Glidewire Stiff and Standard). A human aortic silicon phantom and 2 pigs were used. The study was animal care and use approved by the committee. Under MR-guidance, renal arteries were catheterized, balloon angioplasty was performed, and balloon expandable renal artery stents were deployed in vivo. Post mortem autopsy was performed. Guidewire visibility, pushability, steerability, and device-support capabilities of the marked guidewire were qualitatively assessed. Procedure times were recorded.
RESULTS: Bending stiffness of the new PEEK-based wire was comparable with Standard Glidewire. In vitro and in vivo guidewire guidance, catheter configuration, renal artery catheterization, and balloon angioplasty were successful. In pigs, stent deployments were successful in both renal arteries. Autopsy revealed acceptable stent positioning. Guidewire visibility through applied markers was acceptable. Steerability, pushability, and device support were good in vitro and in vivo.
CONCLUSIONS: The PEEK-based guide allows percutaneous MR-guided renal artery angioplasty and stenting with sufficient visibility, good steerability, pushability, and device support.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252440     DOI: 10.1097/RLI.0b013e31819b00f1

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

1.  Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Authors:  Dong-Hyun Kim; Andrew C Larson
Journal:  Interv Oncol 360       Date:  2016-11-17

2.  Heating and safety of a new MR-compatible guidewire prototype versus a standard nitinol guidewire.

Authors:  Malgorzata Wolska-Krawczyk; Martin A Rube; Erwin Immel; Andreas Melzer; Arno Buecker
Journal:  Radiol Phys Technol       Date:  2013-11-08

3.  MR-guided liver tumor ablation employing open high-field 1.0T MRI for image-guided brachytherapy.

Authors:  Jens Ricke; Markus Thormann; Matthias Ludewig; Kerstin Jungnickel; Oliver Grosser; Christian Wybranski; Nils Peters; Peter Hass; Jürgen Bunke; Frank Fischbach
Journal:  Eur Radiol       Date:  2010-03-20       Impact factor: 5.315

4.  Real-time CMR guidance for intracardiac and great vessel pressure mapping in patients with congenital heart disease using an MR conditional guidewire-results of 25 patients.

Authors:  Christian Meierhofer; Kristina Belker; Nerejda Shehu; Heiner Latus; Naira Mkrtchyan; Susanne Naumann; Stefan Martinoff; Heiko Stern; Andreas Eicken; Peter Ewert
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

5.  Towards real-time cardiovascular magnetic resonance-guided transarterial aortic valve implantation: in vitro evaluation and modification of existing devices.

Authors:  Philipp Kahlert; Holger Eggebrecht; Björn Plicht; Oliver Kraff; Ian McDougall; Brad Decker; Raimund Erbel; Mark E Ladd; Harald H Quick
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-13       Impact factor: 5.364

6.  Multimodal Imaging of Nanocomposite Microspheres for Transcatheter Intra-Arterial Drug Delivery to Liver Tumors.

Authors:  Dong-Hyun Kim; Weiguo Li; Jeane Chen; Zhuoli Zhang; Richard M Green; Sui Huang; Andrew C Larson
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.